HIVE director sells 100K shares at $2.72 average
HIVE Digital Technologies Ltd. (HIVE) director Dave Perrill amended a prior insider report.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
HIVE Digital Technologies Ltd. (HIVE) director Dave Perrill amended a prior insider report. He previously disclosed selling 100,000 Common Shares on August 19, 2026 at a weighted average price of USD$2.7191 (converted from C$3.7765 using a USD$0.72/C$1.00 rate). This amendment adds a previously omitted August 18, 2026 conversion and settlement of 12,500 Restricted Share Units into an equal number of Common Shares under HIVE’s RSU Plan and corrects his beneficial ownership figure to include these shares. Following the RSU transaction, he holds 312,500 RSUs with future vesting tranches through 2027.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Shares F3, F1 | 100,000 | $2.7191 | $272K |
| Exercise | Restricted Share Units F2, F4, F5 | 12,500 | $0.00 | $0.00 |
| Exercise | Common Shares F1, F2 | 12,500 | -- | -- |
Footnotes (5)
- F1. On August 19, 2026, the Reporting Person filed a Form 4 (the "Original Filing") to report the sale of 100,000 shares of the Issuer's common stock. This Form 4/A (this "Amendment") amends the Original Filing to report the conversion and settlement of 12,500 restricted share units ("RSUs") that occurred on August 18, 2026 that was inadvertently omitted from the Original Filing. The Amendment also corrects the amount of Common Stock beneficially owned following the sale reported in the Original Filing to reflect that the Reporting Personâs ownership of these 12,500 shares. Except for the conversion of the RSUs, no additional transaction is being reported in this Amendment.
- F2. Reflects RSUs issued pursuant to the Issuer's Restricted Share Unit Plan (the "RSU Plan") that, upon vesting and settlement converted into shares of the Issuer's common stock on a one-for-one basis.
- F3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from C$3.7300 to C$3.8600, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The weighted average price reported above was converted from the Canadian weighted average price of C$3.7765 to USD$2.7191, using an exchange rate of USD$0.72 to C$1.00.
- F4. Reflects 12,500 RSUs that were awarded on November 5, 2024 and vested on August 5, 2026. These RSUs were settled and converted into common shares of the Issuer on August 18, 2026, in accordance with the Issuer's RSU Plan.
- F5. The RSUs reported under Column 9 include RSUs that were previously reported. The underlying shares and vesting schedules are as follows: (i) 12,500 will vest on November 5, 2026; (ii) 100,000 will vest on October 31, 2026, (iii) 100,000 will vest on March 16, 2027 and (iv) 100,000 will vest on June 30, 2027.
Key Figures
Key Terms
weighted average price financial
beneficially owned financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did HIVE (HIVE) report in this amended Form 4/A?
What RSU activity did HIVE (HIVE) disclose for Dave Perrill?
Why did HIVE (HIVE) file this Form 4/A amendment?
AI-generated analysis. How Rhea-AI works. Not financial advice.